Your browser is no longer supported. Please, upgrade your browser.
Settings
AGTC Applied Genetic Technologies Corporation daily Stock Chart
AGTC [NASD]
Applied Genetic Technologies Corporation
Index- P/E- EPS (ttm)-0.66 Insider Own0.20% Shs Outstand18.35M Perf Week-1.32%
Market Cap68.81M Forward P/E- EPS next Y-1.88 Insider Trans0.00% Shs Float15.11M Perf Month-12.79%
Income-11.90M PEG- EPS next Q-0.41 Inst Own59.70% Short Float1.66% Perf Quarter-1.32%
Sales31.90M P/S2.16 EPS this Y128.60% Inst Trans-2.18% Short Ratio2.33 Perf Half Y-18.48%
Book/sh6.17 P/B0.61 EPS next Y-50.00% ROA-8.20% Target Price8.17 Perf Year-49.32%
Cash/sh6.52 P/C0.58 EPS next 5Y- ROE-10.30% 52W Range3.25 - 8.40 Perf YTD4.17%
Dividend- P/FCF- EPS past 5Y16.50% ROI-0.40% 52W High-55.36% Beta2.18
Dividend %- Quick Ratio6.50 Sales past 5Y105.30% Gross Margin- 52W Low15.38% ATR0.26
Employees72 Current Ratio6.50 Sales Q/Q-55.00% Oper. Margin-36.20% RSI (14)41.86 Volatility4.03% 7.43%
OptionableYes Debt/Eq0.00 EPS Q/Q-396.60% Profit Margin-37.30% Rel Volume0.28 Prev Close3.85
ShortableYes LT Debt/Eq0.00 EarningsFeb 09 BMO Payout- Avg Volume107.99K Price3.75
Recom2.20 SMA20-11.19% SMA50-6.96% SMA200-14.77% Volume30,276 Change-2.60%
Sep-14-17Reiterated Stifel Buy $15 → $12
May-11-17Reiterated Stifel Buy $18 → $15
Mar-15-17Initiated Rodman & Renshaw Buy $16
Nov-09-16Upgrade ROTH Capital Neutral → Buy
Nov-09-16Reiterated Wedbush Outperform $20 → $17
Sep-13-16Reiterated Wedbush Outperform $36 → $20
Sep-13-16Reiterated Stifel Buy $29 → $24
Sep-13-16Downgrade Wells Fargo Outperform → Market Perform
Sep-13-16Downgrade ROTH Capital Buy → Neutral
Sep-13-16Downgrade Cantor Fitzgerald Buy → Hold
Feb-09-16Reiterated Stifel Buy $32 → $29
Dec-04-15Initiated Wells Fargo Outperform
Jul-22-15Initiated Chardan Capital Markets Buy $25
Jul-06-15Reiterated Cantor Fitzgerald Buy $28 → $32
Nov-13-14Reiterated Stifel Buy $29 → $31
Nov-13-14Reiterated ROTH Capital Buy $25 → $34
Oct-03-14Initiated Stifel Buy $29
Feb-14-18 04:05PM  AGTC Announces Sue Washer, CEO, Elected to Biotechnology Innovation Organizations Board of Directors GlobeNewswire
Feb-12-18 07:50AM  Wired News Catalyst Biosciences Shares Positive Top-line Data from Phase-1/2 Study of Subcutaneous CB 2679d for Hemophilia B ACCESSWIRE
Feb-09-18 07:35AM  Applied Genetic Technologies posts 2Q loss Associated Press -7.06%
07:00AM  AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2017 GlobeNewswire
06:30AM  Applied Genetic Technologies Corp. to Host Earnings Call ACCESSWIRE
Feb-01-18 04:05PM  AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 9, 2018 GlobeNewswire -8.08%
Dec-25-17 11:39AM  ETFs with exposure to Applied Genetic Technologies Corp. : December 25, 2017 Capital Cube
Dec-12-17 12:40PM  ETFs with exposure to Applied Genetic Technologies Corp. : December 12, 2017 Capital Cube
Dec-11-17 04:20PM  AGTC to Present at BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference on December 14, 2017 GlobeNewswire
Dec-01-17 10:22AM  ETFs with exposure to Applied Genetic Technologies Corp. : December 1, 2017 Capital Cube
Nov-20-17 11:27AM  ETFs with exposure to Applied Genetic Technologies Corp. : November 20, 2017 Capital Cube
Nov-15-17 09:26AM  Applied Genetic Technologies Corp. :AGTC-US: Earnings Analysis: Q1, 2018 By the Numbers : November 15, 2017 Capital Cube
Nov-13-17 08:31PM  Edited Transcript of AGTC earnings conference call or presentation 7-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-09-17 11:41AM  ETFs with exposure to Applied Genetic Technologies Corp. : November 9, 2017 Capital Cube
Nov-07-17 07:18PM  Is Applied Genetic Technologies Corporation (AGTC) A Sell At Its Current Price? Simply Wall St.
05:56PM  Applied Genetic Technologies posts 1Q loss Associated Press
04:05PM  AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2017 GlobeNewswire
Oct-31-17 07:00AM  AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 7, 2017 GlobeNewswire -8.11%
Oct-27-17 10:42AM  ETFs with exposure to Applied Genetic Technologies Corp. : October 27, 2017 Capital Cube
Oct-16-17 09:47AM  ETFs with exposure to Applied Genetic Technologies Corp. : October 16, 2017 Capital Cube
Oct-06-17 07:00AM  AGTC and the Medical College of Wisconsin Announce Publication of Natural History Data Examining Foveal Cone Structure in Patients with CNGB3-associated Achromatopsia GlobeNewswire
Oct-02-17 10:38AM  ETFs with exposure to Applied Genetic Technologies Corp. : October 2, 2017 Capital Cube
07:30AM  Earnings Review and Free Research Report: Applied Genetic Announced Q4 and Full Year FY17 Results ACCESSWIRE
Sep-29-17 07:00AM  AGTC to Present at Upcoming Gene Therapy Conferences GlobeNewswire +5.33%
Sep-25-17 08:50AM  Applied Genetic Technologies Corp. :AGTC-US: Earnings Analysis: Q4, 2017 By the Numbers : September 25, 2017 Capital Cube
07:00AM  Earnings Review and Free Research Report: Aviragen Reported its Q4 and Full Year FY17 Results ACCESSWIRE
Sep-20-17 07:00AM  AGTC to Present at Upcoming Conferences GlobeNewswire
Sep-19-17 04:52PM  ETFs with exposure to Applied Genetic Technologies Corp. : September 19, 2017 Capital Cube
Sep-18-17 03:03PM  Applied Genetic Technologies Corp. :AGTC-US: Earnings Analysis: 2017 By the Numbers : September 18, 2017 Capital Cube +5.63%
Sep-14-17 01:35AM  Edited Transcript of AGTC earnings conference call or presentation 13-Sep-17 12:00pm GMT Thomson Reuters StreetEvents -8.64%
Sep-13-17 10:29PM  Applied Genetic Technologies posts 4Q loss Associated Press -18.18%
07:00AM  AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June 30, 2017 GlobeNewswire
Sep-05-17 05:53PM  AGTC Appoints Matthew Feinsod, M.D. as Interim Chief Medical Officer GlobeNewswire
Aug-31-17 07:00AM  AGTC to Host Fourth Quarter and Fiscal Year Financial Results Conference Call and Webcast on September 13, 2017 GlobeNewswire
Aug-15-17 07:00AM  AGTC and the Foundation Fighting Blindness Announce Partnership Agreement GlobeNewswire
Aug-10-17 07:00AM  AGTC Files Investigational New Drug Application for the Treatment of X-linked Retinitis Pigmentosa Caused by Mutations in the RPGR Gene GlobeNewswire
Aug-08-17 07:00AM  AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 16, 2017 GlobeNewswire
Aug-07-17 07:00AM  Research Published in Molecular Therapy Identifies Optimal Gene-based Therapeutic Construct for X-Linked Retinitis Pigmentosa GlobeNewswire
Aug-03-17 04:01PM  AGTC Announces U.S. FDA Orphan Drug Designation for Gene Therapy to Treat X-Linked Retinitis Pigmentosa GlobeNewswire
Aug-02-17 04:01PM  AGTC Appoints William Sullivan as Chief Financial Officer, Andrew Ashe Named General Counsel GlobeNewswire
Jul-31-17 04:21PM  ETFs with exposure to Applied Genetic Technologies Corp. : July 31, 2017 Capital Cube
Jul-13-17 03:24PM  ETFs with exposure to Applied Genetic Technologies Corp. : July 13, 2017 Capital Cube
Jul-03-17 02:47PM  ETFs with exposure to Applied Genetic Technologies Corp. : July 3, 2017 Capital Cube
Jun-19-17 02:51PM  ETFs with exposure to Applied Genetic Technologies Corp. : June 19, 2017 Capital Cube
Jun-16-17 11:58AM  Applied Genetic Technologies Corp. :AGTC-US: Earnings Analysis: Q3, 2017 By the Numbers : June 16, 2017 Capital Cube
Jun-15-17 07:00AM  IND-Enabling Study Data Published in Human Gene Therapy Clinical Development Support Clinical Development of AGTC-402 for the Treatment of CNGA3-deficient Achromatopsia GlobeNewswire
Jun-08-17 04:01PM  AGTC Announces Topline Safety Data for X-Linked Retinoschisis Phase 1/2 Study GlobeNewswire
07:00AM  Data Published in Molecular Therapy Demonstrate Five-Year Response Following a Single Dose of an Investigational Gene-Based Therapy for Alpha-1 Antitrypsin (AAT) Deficiency GlobeNewswire
May-11-17 07:00AM  AGTC Presents New Data on its AAV-Based Gene Therapies for the Treatment of Achromatopsia and X-Linked Retinitis Pigmentosa at the American Society of Gene and Cell Therapy 20th Annual Meeting GlobeNewswire -5.04%
May-10-17 05:30PM  Applied Genetic Technologies posts 3Q loss Associated Press
04:08PM  AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2017 GlobeNewswire
10:30AM  Investor Network: Applied Genetic Technologies Corp. to Host Earnings Call Accesswire
May-09-17 07:01AM  AGTC and Collaborators Present New Data on the Natural History of X-Linked Retinoschisis (XLRS) at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting GlobeNewswire
May-02-17 07:00AM  AGTC to Host Third Quarter Financial Results Conference Call and Webcast on May 10, 2017 GlobeNewswire
May-01-17 03:33PM  ETFs with exposure to Applied Genetic Technologies Corp. : May 1, 2017 Capital Cube
Apr-20-17 07:00AM  AGTC to Present at the 5th Annual Cell & Gene Therapy Investor Day on April 27, 2017 GlobeNewswire
Apr-19-17 02:08PM  ETFs with exposure to Applied Genetic Technologies Corp. : April 19, 2017 Capital Cube
Apr-05-17 04:15PM  ETFs with exposure to Applied Genetic Technologies Corp. : April 5, 2017 Capital Cube
Mar-15-17 09:33AM  Applied Genetic Technologies Corp. :AGTC-US: Earnings Analysis: Q2, 2017 By the Numbers : March 15, 2017 Capital Cube
07:05AM  Coverage initiated on Applied Genetic Technologies by Rodman & Renshaw
Mar-09-17 06:02PM  Perrigo Launches First to Market OTC Equivalent of Rogaine Zacks
09:15AM  Spectrum (SPPI) Q4 Loss Narrower than Expected, Sales Beat
Mar-06-17 10:46AM  Applied Genetic Technologies (AGTC) Shares March Higher, Can It Continue? Zacks -7.78%
Mar-03-17 07:00AM  AGTC to Present at the 29th Annual ROTH Conference on March 14, 2017 GlobeNewswire
Mar-02-17 04:02PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
09:06AM  Tenet Healthcare (THC) to Divest Operations to Amedisys Zacks
09:04AM  Molina Healthcare (MOH) Issues Revised Q4 & 2016 Results
08:40AM  Global Blood Therapeutics (GBT) in Focus: Stock Jumps 6.8%
Mar-01-17 08:30AM  Idera Pharmaceuticals (IDRA) Looks Good: Stock Up 13.3%
Feb-14-17 01:04PM  APPLIED GENETIC TECHNOLOGIES CORP Financials
Feb-10-17 04:01PM  AGTC Selected as Top Company in the University of Floridas 2017 Gator100 GlobeNewswire +6.57%
02:15PM  Seattle Genetics (SGEN) Loss Wider than Expected in Q4, Revenues Miss
Feb-08-17 07:15PM  Applied Genetic Technologies posts 2Q profit Associated Press
04:33PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem
04:33PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
04:10PM  AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2016 GlobeNewswire
07:07AM  Q2 2017 Applied Genetic Technologies Corp Earnings Release - After Market Close
Feb-02-17 07:15AM  AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 8, 2017 GlobeNewswire
Jan-24-17 07:00AM  AGTC and Bionic Sight Announce Strategic Collaboration to Develop an Optogenetic Therapy and Device for Visual Deficits and Blindness GlobeNewswire
Jan-12-17 08:45AM  Implied Volatility Surging for Applied Genetic Technologies (AGTC) Stock Options
07:00AM  AGTC to Present at Phacilitate Cell & Gene Therapy World 2017 GlobeNewswire
Dec-22-16 12:47PM  ETFs with exposure to Applied Genetic Technologies Corp. : December 22, 2016
Dec-19-16 12:48PM  Big Changes to BioShares Biotech ETFs: Who's In, Who's Out? +5.71%
Dec-08-16 04:05PM  Applied Genetic Technologies Corp (AGTC): Are Hedge Funds Right About This Stock? at Insider Monkey
Dec-05-16 07:00AM  AGTC to Present at Upcoming Conferences GlobeNewswire +6.15%
Nov-29-16 03:02PM  ETFs with exposure to Applied Genetic Technologies Corp. : November 29, 2016
Nov-28-16 10:02AM  Applied Genetic Technologies Corp. :AGTC-US: Earnings Analysis: Q1, 2017 By the Numbers : November 28, 2016 -7.07%
Nov-18-16 01:20PM  These 5 Stocks Are Ready to Break Out
Nov-17-16 04:16PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers
04:01PM  AGTC Appoints Michael Goldstein, M.D. as Chief Medical Officer GlobeNewswire
Nov-08-16 05:08PM  Applied Genetic Technologies posts 1Q profit
04:18PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 8-K, Change in Directors or Principal Officers
04:09PM  AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2016 GlobeNewswire
04:04PM  APPLIED GENETIC TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
07:07AM  Q1 2017 Applied Genetic Technologies Corp Earnings Release - After Market Close
Nov-03-16 07:00AM  AGTC to Present at the Stifel 2016 Healthcare Conference on November 15, 2016 GlobeNewswire
Oct-27-16 07:00AM  AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 8, 2016 GlobeNewswire -5.66%
Oct-19-16 04:01PM  AGTC Files Investigational New Drug Application for the Treatment of Achromatopsia Caused by Mutations in the CNGA3 Gene GlobeNewswire
Oct-18-16 09:37AM  ETFs with exposure to Applied Genetic Technologies Corp. : October 18, 2016
Oct-04-16 07:00AM  AGTC to Present at Upcoming Scientific Conferences GlobeNewswire
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's lead products consist of four ophthalmology development programs across three targets, including X-linked retinoschisis that is in Phase I/II clinical trials; X-linked retinitis pigmentosa, which is in Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials for the treatment of inherited retinal diseases, as well as a preclinical program in adrenoleukodystrophy, which is a disease of the central nervous system and otology. It has collaboration agreements with Biogen MA, Inc., 4D Molecular Therapeutics, Synpromics Limited, and Bionic Sight, LLC, as well as the University of Florida Research Foundation. The company was founded in 1999 and is headquartered in Alachua, Florida.